| Centracare Health System - Melrose Pine Villa C C | |
| 525 West Main Street, Melrose, Minnesota 56352 | |
| (320) 256-4231 | |
| Name | Centracare Health System - Melrose Pine Villa C C |
|---|---|
| Location | 525 West Main Street, Melrose, Minnesota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 75 |
| Occupancy Rate | 68.8% |
| Medicare ID (CCN) | 245396 |
| Legal Business Name | Centracare Health System - Melrose |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1366400822 |
| Organization Name | CURA OF MELROSE LLC |
| Doing Business As | PINE VILLA CARE CENTER |
| Address | 525 Main St W, Melrose, MN 56352 |
| Phone Number | 320-256-4231 |
News Archive
General Dynamics today completed its acquisition of Vangent Holding Corp., the parent company of Vangent, Inc., a leading provider of healthcare information technology and business systems to federal agencies.
Your high school graduate is off to college to embark on a newly independent life. But they're not the only one making a transition: parents too face emotional and lifestyle adjustments. With advice on empty-nest syndrome and the college transition, NewYork-Presbyterian Hospital physicians offer expert tips for parents and children on topics including redecorating your child's room, credit cards, keeping in touch and more.
A new analysis has found that a decline in hormone therapy (HT) use among women aged 50 to 64 years is linked with lower mammogram rates among these women.
Columbia University Medical Center announced plans today to build a new home for the Columbia University School of Nursing, one of the oldest nursing schools in the nation. The seven-story building will be located on existing Columbia property at the corner of W. 168th Street and Audubon Avenue, at the east end of the CUMC campus. Construction is expected to begin in late 2014.
AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets). The treatment has been approved with or without ribavirin (RBV) for patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
General Dynamics today completed its acquisition of Vangent Holding Corp., the parent company of Vangent, Inc., a leading provider of healthcare information technology and business systems to federal agencies.
Your high school graduate is off to college to embark on a newly independent life. But they're not the only one making a transition: parents too face emotional and lifestyle adjustments. With advice on empty-nest syndrome and the college transition, NewYork-Presbyterian Hospital physicians offer expert tips for parents and children on topics including redecorating your child's room, credit cards, keeping in touch and more.
A new analysis has found that a decline in hormone therapy (HT) use among women aged 50 to 64 years is linked with lower mammogram rates among these women.
Columbia University Medical Center announced plans today to build a new home for the Columbia University School of Nursing, one of the oldest nursing schools in the nation. The seven-story building will be located on existing Columbia property at the corner of W. 168th Street and Audubon Avenue, at the east end of the CUMC campus. Construction is expected to begin in late 2014.
AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets). The treatment has been approved with or without ribavirin (RBV) for patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with compensated liver cirrhosis, HIV-1 co-infection, patients on opioid substitution therapy and liver transplant recipients.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.75 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.45 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 42.7 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.58 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.07 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.29 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 10.29 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.59 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.11 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.36 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 20.93 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 8.14 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 14.02 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.21 | 95.98 |